What Is Co-Arinate Adult and What Is It Used For?
Co-Arinate Adult is a fixed-dose
combination antimalarial for the curative treatment of uncomplicated malaria,
including multidrug-resistant Plasmodium falciparum strains. Artesunate rapidly
clears parasitaemia, while sulfamethoxypyrazine and pyrimethamine act synergistically
as antifolate/sulfonamide partner drugs to prevent recrudescence.
Co-Arinate Adult is used as a
curative treatment across all forms of malaria within a 48-hour treatment
window, and is intended for adults and patients above the paediatric weight
range covered by Co-Arinate Junior.
4. How to Take This Medicine
Dosing Schedule
One tablet immediately on
diagnosis (approximately 4mg/kg artesunate for the standard adult weight
range), one tablet 24 hours later, and one tablet a further 24 hours after that
— three tablets total over 48 hours.
Critical Timing
A strict 24-hour interval must
be maintained between each dose; taking doses too close together or too far
apart reduces effectiveness and encourages resistance.
Higher Body Weight
Adults above 80kg may need dose
adjustment — confirm with the prescriber.
5. Side Effects
Common Side Effects
• Nausea
• Vomiting
• Abdominal discomfort
• Dizziness
• Headache
Uncommon Side Effects
• Rash
• Itching (sulfonamide
sensitivity)
Serious Side Effects — Seek
Immediate Medical Attention
• Severe skin reactions
(Stevens-Johnson syndrome), sulfonamide-related
• Haemolysis in G6PD-deficient
individuals, dark urine, jaundice
• Blood dyscrasias with prolonged
or repeated antifolate exposure
6. Contraindications
|
⚠ The following patients should NOT use this medication: • Known hypersensitivity to
sulfonamides, artesunate, or pyrimethamine • G6PD deficiency (increased
haemolysis risk) • Severe hepatic or renal
impairment • First-trimester pregnancy: confirm current national malaria
treatment guideline positioning with the prescriber |
7. Safety Warnings and Special Precautions
• National Treatment Positioning: Kenya's national first-line
treatment for uncomplicated malaria is Artemether-Lumefantrine (AL) per
Ministry of Health/NMCP guidelines. Co-Arinate is generally used as an
alternative ACT, for example where AL is unsuitable or unavailable.
• Strict Dosing Interval: The 24-hour spacing between
doses is essential for efficacy — reinforce this explicitly with patients, as
it is a common point of non-adherence.
• Confirm Diagnosis First: Confirm malaria diagnosis by RDT
or microscopy before treatment; do not use presumptively, in line with
antimalarial resistance stewardship.
8. Drug Interactions
• Other antifolate drugs (e.g.
trimethoprim-sulfamethoxazole/co-trimoxazole, methotrexate): Additive bone marrow suppression
risk — avoid concurrent use where possible.
• Other sulfonamide-based
medicines: Cross-sensitivity
risk — check allergy history carefully before dispensing.
9. Storage Instructions
• Store below 30°C, dry place,
protected from moisture and direct sunlight.
• Keep out of reach of children.
10. Prescription Status in Kenya
Co-Arinate Adult is a
Prescription Only Medicine (POM), dispensed against a confirmed malaria diagnosis
in line with PPB and national malaria treatment guidelines.
11. Patient Guidance
|
💊 Key Points for Patients: ✔ Take all three tablets exactly
24 hours apart — do not skip doses or take them closer together, even if you
feel better after the first tablet. ✔ Complete the full course. ✔ Return promptly if symptoms
worsen, or if you develop a rash, yellowing of the eyes/skin, or unusually
dark urine. ✔ Discuss with your doctor if
you are pregnant before starting treatment. |
12. Pharmacist / Prescriber Notes
Confirm parasitological
diagnosis before dispensing — avoid presumptive treatment, consistent with
antimalarial resistance stewardship.
Ask about known G6PD status
where feasible, particularly in populations with higher G6PD deficiency prevalence.
Reinforce the strict 24-hour
dosing interval, and flag to prescribers that this is a second-line/alternative
ACT relative to AL under current Kenyan malaria treatment policy.
13. Frequently Asked Questions (FAQs)
Q1: Why is there a 24-hour gap between each tablet?
A: This spacing is essential to how
the combination clears the parasite — taking doses too close together or too
far apart reduces effectiveness.
Q2: Can I take this if I'm pregnant?
A: Discuss with your doctor —
pregnancy requires specific antimalarial protocols, especially in the first
trimester.
Q3: What if I vomit shortly after taking a dose?
A: Contact your pharmacist or
doctor — a repeat dose may be needed depending on timing.
Q4: Is this the standard malaria treatment in Kenya?
A: Artemether-Lumefantrine is the
standard first-line treatment; Co-Arinate is used as an alternative in specific
situations.
Q5: Can I stop once I feel better?
A: No — complete all three doses on
schedule to fully clear the infection and prevent recurrence or resistance.
There are no product reviews yet.